XML 46 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Organization and Nature of the Business - Additional Information (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 9 Months Ended
Sep. 15, 2020
Sep. 15, 2020
Feb. 28, 2021
USD ($)
$ / shares
shares
Sep. 30, 2021
USD ($)
shares
Dec. 31, 2020
USD ($)
shares
Schedule Of Equity Method Investments [Line Items]          
Entity incorporation date       Nov. 30, 2014  
Entity date of merger       Apr. 28, 2020  
Equity method investment, Ownership percentage       25.00%  
Reverse stock split 1-for-7 1-for-7      
Exchange ratio   0.1240      
Common stock, shares outstanding | shares       31,955,050 19,677,249
Accumulated deficit       $ (152,511) $ (106,325)
Adicet Therapeutics [Member]          
Schedule Of Equity Method Investments [Line Items]          
Equity method investment, Ownership percentage       75.00%  
Common stock, shares outstanding | shares       19,589,828  
Accumulated deficit       $ 152,500  
Initial Public Offering          
Schedule Of Equity Method Investments [Line Items]          
Number of common stock shares sold | shares     10,575,513    
Issuance price per shares | $ / shares     $ 13.00    
Underwriting discounts and commissions and other offering expenses     $ 137,500    
Net proceeds received from offering     $ 15,000